Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Adjusted SG&A % of Revenue by Quarter
Adjusted SG&A % of Revenue (%)
Thermo Fisher Scientific Adjusted SG&A % of Revenue: 15.5% in Q3 2026, unchanged from a year earlier.
Latest, Q3 2026
15.5%
Period ended Sep 30, 2026
Change on a year earlier
0.0 pts
15.5% in Q3 2025
History
15 quarters
Since Q1 2023
Sources
3
Documents cited below
Where the Q3 2026 figure comes from
“Adjusted SG&A expense (non-GAAP measure) 1,707 16.5 % 1,759 16.2 % 1,729 15.5 % 1,870 15.3 % 1,755 16.0 % 1,872 15.6 % 1,883 15.5 %”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific Adjusted SG&A % of Revenue (%), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/adj-sga-pct
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.